Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
06/25/1998 | WO1998026776A1 Method for treating renal failure |
06/25/1998 | WO1998026775A1 Phenylethylamine derivatives |
06/25/1998 | WO1998026774A1 Compositions based on aminoacids |
06/25/1998 | WO1998026773A1 Use of matrix metalloproteinase inhibitors for treating neurological disorders and promoting wound healing |
06/25/1998 | WO1998026772A1 Sustained release pharmaceutical tablets with tramadol base and their preparation |
06/25/1998 | WO1998026771A1 Use of c18 to c26 aliphatic alcohols for the manufacture of a medicament in the treatment of hyperproliferative skin disorders |
06/25/1998 | WO1998026770A2 The topical use of kappa opioid agonists to treat ocular pain |
06/25/1998 | WO1998026769A1 Adp-ribosyltransferase inhibitor |
06/25/1998 | WO1998026768A2 Use of 7-(1-aminomethyl-2-oxa-7-aza-bicyclo[3.3.0]oct-7-yl)-quinolone carboxylic acid and naphthyridone carboxylic acid derivatives for treating helicobacter pylori infections and the gastroduodenal diseases associated therewith |
06/25/1998 | WO1998026767A2 Site-specific controlled release dosage formulation for mesalamine |
06/25/1998 | WO1998026763A1 Active substance carrier for releasing apomorphine into the buccal cavity |
06/25/1998 | WO1998026762A1 Homogeneous preformulations containing wigh concentrations of steroids, for producing low-dose solid and semi-solid pharmaceutical preparations |
06/25/1998 | WO1998022101A3 Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents |
06/25/1998 | WO1998022100A3 New use for 1,3-propanediol derivatives |
06/25/1998 | WO1998021182A3 Use of cis-δ4 analogs of prostaglandins as ocular hypotensives |
06/25/1998 | WO1998019649A3 Methods and compositions for inhibition of angiogenesis |
06/25/1998 | WO1998017268A3 Method of alleviating pain by means of combining tramadol with an nmda antagonist |
06/25/1998 | WO1998017266A3 Pharmaceutical preparation |
06/25/1998 | WO1998016504A3 SULFONAMIDE SUBSTITUTED ASPARTIC ACID INTERLEUKIN-1β CONVERTING ENZYME INHIBITORS |
06/25/1998 | WO1998012220A3 Novel tumor proteins |
06/25/1998 | WO1998012190A3 Phenoxathiin derivatives as inhibitors of monoamine oxidase |
06/25/1998 | WO1998011887A3 Viral inhibition by long-chain alcohols, alkanes, fatty acids and amides |
06/25/1998 | WO1998010750A3 Nucleic acid particle delivery |
06/25/1998 | WO1998009668A3 Use of amphiphiles as phosphatidyl choline synthesis inhibitors |
06/25/1998 | WO1998007449A3 Polymer bile acid resorption inhibitors with simultaneous bile acid adsorbing effect |
06/25/1998 | WO1998005769A3 Antitumor antisense sequences directed against r1 and r2 components of ribonucleotide reductase |
06/25/1998 | WO1998002151A3 Chemokine receptor antagonists and methods of use therefor |
06/25/1998 | DE19654609A1 Therapeutische Gestagene zur Behandlung von Premenstrual Dysphoric Disorder Therapeutic progestogens for the treatment of Premenstrual Dysphoric Disorder |
06/25/1998 | DE19654079A1 Endo-ekto-parasitizide Mittel Endo-ecto-parasiticidal agent |
06/25/1998 | DE19653225A1 New creatine pyruvate derivatives from crystallisation in polar solvents |
06/25/1998 | CA2275610A1 Modulators of proteins with phosphotyrosine recognition units |
06/25/1998 | CA2275507A1 Prebiotics and probiotics |
06/25/1998 | CA2275492A1 Sulphonamide derivatives, process for their preparation, and their use as medicaments |
06/25/1998 | CA2275478A1 Piperazine compounds as inhibitors of mmp or tnf |
06/25/1998 | CA2275454A1 Polypeptides of the "basic-helix-loop-helix" bhlh family, corresponding nucleic acid sequences |
06/25/1998 | CA2275346A1 New 4-(1-piperazinyl)benzoic acid derivatives, process for preparing them and their therapeutic applications |
06/25/1998 | CA2275256A1 Heterocyclic carboxylic acid derivatives, the production and use thereof as endothelin receptor antagonists |
06/25/1998 | CA2274934A1 Sustained release pharmaceutical tablets with tramadol base and their preparation |
06/25/1998 | CA2274893A1 Active substance carrier for releasing apomorphine into the buccal cavity |
06/25/1998 | CA2274892A1 Use of 7-(1-aminomethyl-2-oxa-7-aza-bicyclo[3.3.0]oct-7-yl)-quinolone carboxylic acid and naphthyridone carboxylic acid derivatives for treating helicobacter pylori infections andthe gastroduodenal diseases associated therewith |
06/25/1998 | CA2274779A1 Aminosterol ester compounds |
06/25/1998 | CA2274651A1 Remedies/preventives for abnormal motions accompanying disorders in extrapyramidal system |
06/25/1998 | CA2274055A1 N-piperazin-1-ylphenyl-benzamide derivatives |
06/25/1998 | CA2273480A1 Ophtalmic viscoelastic compositions |
06/25/1998 | CA2273288A1 Method of treating or inhibiting neutropenia |
06/25/1998 | CA2273286A1 Process for the preparation of nmda antagonists |
06/25/1998 | CA2264692A1 Use of matrix metalloproteinase inhibitors for treating neurological disorders and promoting wound healing |
06/24/1998 | EP0849280A2 Fucans with low molecular weight having anticoagulant, antithrombinic and antithrombotic activity |
06/24/1998 | EP0849269A1 Vinyl pyrrolidine cephalosporins with basic substituents |
06/24/1998 | EP0849266A1 Novel polymorphic form of doxazosin mesylate (form III) |
06/24/1998 | EP0849265A1 Novel polymorphic form of doxazosin mesylate (form II) |
06/24/1998 | EP0849264A1 Novel polymorphic form of doxazosin mesylate (form I) |
06/24/1998 | EP0849263A2 Pharmaceutical substituted propanoic acid derivatives |
06/24/1998 | EP0849261A1 Piperazinophenyl- and piperazinophenyloxy-carboxylic acid derivatives as well as processes and intermediates for their preparation and medicaments containing these compounds |
06/24/1998 | EP0849256A1 Amide compounds and use of the same |
06/24/1998 | EP0848955A1 Anti-stress agent for animals comprising an ascorbic acid derivative |
06/24/1998 | EP0848954A1 Method for promoting ovulation, parturition and lactation in mammals |
06/24/1998 | EP0848953A1 5-Hydroxy- and 5-acyloxy-2,3-dihydro-4,6,7-trimethyl-2-benzofurane-acetic acids and their esters for treating and preventing diabetic complications |
06/24/1998 | EP0848952A1 Use of lower alkanoyl l-carnitines to produce a medicament suitable for the therapeutic treatment of retinopathies |
06/24/1998 | EP0848951A1 Use of acetylcysteine for the manufacture of a medicament for the treatment of chronic ulcers |
06/24/1998 | EP0848949A1 Aerosol containing vitamin A or a derivative thereof |
06/24/1998 | EP0848758A1 Targeted nucleotide sequence delivery and integration system |
06/24/1998 | EP0848757A1 The use of the wap of mmtv regulatory sequences for targeted expression of linked heterologous genes in human mammary cells, including human mammary carcinoma cells |
06/24/1998 | EP0848755A1 Vegf-related protein |
06/24/1998 | EP0848736A1 Acid resistant calcium carbonate composition containing an aluminum salt and uses therefor |
06/24/1998 | EP0848720A2 Antagonists of the oncogenic activity of the protein mdm2, and use thereof in the treatment of cancers |
06/24/1998 | EP0848717A1 Process for the preparation of imidazolyl macrolide immunosuppressants |
06/24/1998 | EP0848712A1 Dihydropyran derivatives as viral neuraminidase inhibitors |
06/24/1998 | EP0848708A1 N,n-di(arylmethyl)cyclic urea derivatives as anti-coagulants |
06/24/1998 | EP0848707A1 4-(cycloalkyl)piperidines and 4-(cycloalkylalkyl)-piperidines derivatives, preparation thereof and therapeutical applications thereof |
06/24/1998 | EP0848706A1 Substituted benzene-fused hetero- and carbocyclics as neurokinin antagonists |
06/24/1998 | EP0848705A1 Crystalline r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4- (phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) |
06/24/1998 | EP0848704A1 Form iii crystalline [r-(r*,r*)]-2-(4-fluorophenyl)-beta-delta-dihydroxy-5-(1-methyl-ethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) |
06/24/1998 | EP0848703A1 Derivatives of benzosulphonamides as inhibitors of the enzyme cyclo-oxygenase ii |
06/24/1998 | EP0848696A1 2,4-pentadienoic acid derivatives having retinoid-like biological activity |
06/24/1998 | EP0848620A1 Agent, for transdermal application, containing esters of 3-ketodesogestrel |
06/24/1998 | EP0848615A1 Multi-subtype fiv vaccines |
06/24/1998 | EP0848613A1 Analogs for specific oligosaccharide-neuregulin interactions and uses thereof |
06/24/1998 | EP0848612A2 Use of calendula glycosides for the treatment of psoriasis |
06/24/1998 | EP0848610A1 Use of a carbostyril derivative for inhibiting carcinogenesis |
06/24/1998 | EP0848609A1 Use of tiamulin for preparing a drug for use as a cancer multidrug resistance reversion agent |
06/24/1998 | EP0848607A1 Pharmaceutical compositions and devices for their administration |
06/24/1998 | EP0848592A1 Antistress agents for aquatic animals |
06/24/1998 | EP0751785B1 Combinations of thrombolytically active proteins and anticoagulants, and uses thereof |
06/24/1998 | EP0700380B1 N-alkylthio polyamine derivatives as radioprotective agents |
06/24/1998 | EP0680468B1 Substituted amino compounds, their preparation and their use as inhibitors of thrombocyte aggregation |
06/24/1998 | EP0679161B1 Thiazolidine derivatives, preparation thereof and drugs containing same |
06/24/1998 | EP0666842B1 Hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors |
06/24/1998 | EP0658117B1 Treatment of tumors with neurotrophic factors and cell proliferation inhibitors |
06/24/1998 | EP0554363B1 Alteration of rate and character of hair growth |
06/24/1998 | CN1185786A Sugar-modified cytostatics |
06/24/1998 | CN1185783A Esters of carbapenems |
06/24/1998 | CN1185742A Protein kinase c inhibitors |
06/24/1998 | CN1185738A Anticancer substance suppressing cancerous metastasis |
06/24/1998 | CN1185737A Isothiazolones |
06/24/1998 | CN1185736A Use of thiazolium compounds for preventing and preverting the formation of advanced glycosylation endproducts |
06/24/1998 | CN1185735A Sorbic-acid-containing hydrogels |
06/24/1998 | CN1185734A Method of altering the contents of eggs |
06/24/1998 | CN1185716A Insecticidal composition effective against fleas on mammals particularly cats and dogs |
06/24/1998 | CN1185435A Sulfamide-substituted compound, preparation method, and medicinal preparation containing same |